AllisonJuneKaedingMD

Pediatric Hematologic Oncology

Acting Instructor, Pediatric Blood & Marrow Transplantation, University of Washington/Seattle Cancer Care Alliance

Dr. Kaeding is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

113 citations
The natural history of soy allergy
Jessica H. Savage, Allison J. Kaeding, Elizabeth C. Matsui, Robert A. Wood
The Journal of Allergy and Clinical Immunology. 2009-02-01
4 citations
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
Anilkumar Gopalakrishnapillai, Colin Correnti, Kristina Pilat, Ida Lin, Man Kid Chan
Cancers. 2021-11-26
19 citations
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia.
Allison Kaeding, Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo
Blood Advances. 2021-05-11

Abstracts/Posters

In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018